ライフサイエンスコーパス: live donor liver transplantation

1 eceived OLT, including two who had undergone live-donor liver transplantation.

2 the first national guideline in the field of living donor liver transplantation.

3 that contribute to biliary complications in living donor liver transplantation.

4 ion were examined and compared with those of living donor liver transplantation.

5 s, the results were comparable with those of living donor liver transplantation.

6 recipient and donor outcomes associated with living donor liver transplantation.

7 carcinoma recurrence has been reported with living donor liver transplantation.

8 , thereby increasing pressures on the use of living donor liver transplantation.

9 parable to those for SD without resorting to living donor liver transplantation.

10 ating to the advantages and disadvantages of living donor liver transplantation.

11 timation of graft volume (GV) is critical in living donor liver transplantation.

12 horts with HCC undergoing either deceased or living donor liver transplantation.

13 rform cadaveric liver transplantation; or 3) living donor liver transplantation.

14 ght ratio of 0.8% is adequate for right lobe living donor liver transplantation.

15 f the different techniques used in pediatric living-donor liver transplantation.

16 done with the "orphan graft" in all cases of living-donor liver transplantation; (2) avoid the premat

17 Preoperative evaluation of donors for living-donor liver transplantation aims to select a suit

18 on are cardinal components of adult-to-adult live donor liver transplantation (ALDLT).

19 Adult-to-adult living donor liver transplantation (ALDLT) is being incr

20 BO-incompatible (ABOi) dual-graft (DG) adult living donor liver transplantation (ALDLT) is not common

21 erience in adult-to-adult right hepatic lobe living donor liver transplantation (ALDLT) using extensi

22 er right hepatectomy (RH) for adult-to-adult living donor liver transplantation (ALDLT).

23 bosis (HAT) and patient survival after adult living donor liver transplantation (ALDLT).

24 inical factors to recipient outcome in adult living donor liver transplantation (ALDLT).

25 pansion of the pool of donors has focused on live donor liver transplantation and extended criteria d

26 adaver split liver transplantation and adult living donor liver transplantation and possibly, in the

27 The results of live donor liver transplantation are equivalent to those

28 The recipient outcomes with living donor liver transplantation are comparable to tho

29 ords of donors and recipients, who underwent living donor liver transplantation at our institution be

30 a girl with Hardikar syndrome who underwent living-donor liver transplantation at 2 years of age.

31 Adult living donor liver transplantation can be performed safe

32 HCV-infected patients in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)

33 The Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)

34 l Institutes of Health-funded Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL),

35 rative complications from the Adult-to-Adult Living Donor Liver Transplantation Cohort study (A2ALL),

36 investigated in the 9-center Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).

37 were reviewed as part of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).

38 nt candidates enrolled in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study after Fe

39 The Adult-to-Adult Living Donor Liver Transplantation Cohort Study is a pro

40 The adult-to-adult living donor liver transplantation cohort study is provi

41 r surgery and enrolled in the Adult-to-Adult Living Donor Liver Transplantation cohort study provides

42 A principal aim of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study was to s

43 ts (963 LDLT) enrolled in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study who rece

44 ansplant were enrolled in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, includi

45 In the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, patient

46 The advent of living donor liver transplantation for adult recipients

47 The increased recurrence risk with living donor liver transplantation for hepatocellular ca

48 Living donor liver transplantation has become a life-sav

49 Living donor liver transplantation has become an importa

50 Living donor liver transplantation has gained wide accep

51 Living donor liver transplantation has recently been rep

52 Living-donor liver transplantation has helped to allevia

53 Developing strategies for transfusion-free live donor liver transplantation in Jehovah's Witness pa

54 The role of living donor liver transplantation in hepatocellular car

55 Clearly, the role of living donor liver transplantation in management of pati

56 Donor selection limits the application of living donor liver transplantation in the adult populati

57 There are limited data on the efficacy of living donor liver transplantation in the setting of HCC

58 ished by liver transplantation, we performed living donor-liver transplantation in an infant with eth

59 with the use of extended criteria donors and live donor liver transplantation is a major challenge.

60 Left lateral sectionectomy for pediatric live donor liver transplantation is a well-standardized

61 ic retrieval of the left lateral section for live donor liver transplantation is safe and reproducibl

62 Live donor liver transplantation is the predominant form

63 Living donor liver transplantation is a viable strategy

64 Adult living donor liver transplantation is being evaluated as

65 A wider application of living donor liver transplantation is limited by donor m

66 Living donor liver transplantation is mainly restricted

67 Living-donor liver transplantation is an accepted techni

68 he treatment of anastomosis strictures after live donor liver transplantation (LDLT) because they can

69 augmentation and conservation practices with live donor liver transplantation (LDLT) to accomplish su

70 jejunostomy (HJ) is usually performed during live donor liver transplantation (LDLT) when a duct-to-d

71 Some transplant centers have begun offering living donor liver transplantation (LDLT) for selected p

72 Living donor liver transplantation (LDLT) has been contr

73 Early allograft dysfunction (EAD) after living donor liver transplantation (LDLT) has often been

74 /UNOS) data from 2002-2012 to assess whether living donor liver transplantation (LDLT) has surpassed

75 ume, outcomes, uniqueness, and challenges of living donor liver transplantation (LDLT) in Latin Ameri

76 opic approach in right hepatectomy (LRH) for living donor liver transplantation (LDLT) is a controver

77 ty from donation of a right hepatic lobe for living donor liver transplantation (LDLT) is an importan

78 rpose of donor evaluation for adult-to-adult living donor liver transplantation (LDLT) is to discover

79 The data about elderly recipient after living donor liver transplantation (LDLT) is unsatisfact

80 Centers offering adult living donor liver transplantation (LDLT) mostly use rig

81 th hepatocellular carcinoma (HCC) listed for living donor liver transplantation (LDLT) or brain-dead

82 rmine the outcome of venous conduits used in living donor liver transplantation (LDLT).

83 can be used to predict HCC recurrence after living donor liver transplantation (LDLT).

84 More than 2000 adult-to-adult living donor liver transplantations (LDLT) have been per

85 Living-donor liver transplantation (LDLT) has been perfo

86 An important long-term consideration for living-donor liver transplantation (LDLT) is the expense

87 Despite the advantages of living-donor liver transplantation (LDLT), the procedure

88 he most challenging parts of right lobe (RL) living donor liver transplantations (LDLTs).

89 There has been concern that adult living-donor liver transplantation (LLTx) for hepatitis

90 21) and evaluation as a potential donor for living donor liver transplantation (n = 16).

91 was higher than that for the recipients with living donor liver transplantation (P < 0.001).

92 Right lobe living donor liver transplantation poses challenges that

93 Adult living-donor liver transplantation recipients undergo im

94 d a hemodynamic monitoring protocol in adult living-donor liver transplantation recipients, which eva

95 Balancing donor and recipient risks in living donor liver transplantation remains an issue of d

96 Data from the 9-center Adult-to-Adult Living Donor Liver Transplantation retrospective cohort

97 Living-donor liver transplantation should confer a subst

98 to primary or metastatic liver tumors, or in living donor liver transplantation, strategies to quell

99 nces in liver surgery gleaned from split and live donor liver transplantation that necessitate hepati

100 We report two cases of adult to adult living donor liver transplantation using a right hepatic

101 Donor selection criteria for adult-to-adult living donor liver transplantation vary with the medical

102 itish Transplantation Society Guidelines for Living Donor Liver Transplantation was published in July

103 Living-donor liver transplantation was the best strategy

104 d PVP is associated with liver failure after living donor liver transplantation, we hypothesized that